908 Devices goes public
Boston-based 908 Devices, a provider of analytical devices for chemical and biomolecular analysis, has raised $130 million for its IPO after pricing its 6.5 million shares at $20 per share.
Boston-based 908 Devices, a provider of analytical devices for chemical and biomolecular analysis, has raised $130 million for its IPO after pricing its 6.5 million shares at $20 per share.
Copyright PEI Media
Not for publication, email or dissemination